Table 8:
Mortality With Mechanical Thrombectomy Use in Arterial Acute Limb Ischemia
Author, year | Outcome measurement | Results | P value | |
---|---|---|---|---|
MT | Comparator | |||
PMT (AngioJet) | ||||
Byrne et al, 201476 | 1 y survival 2 y survival Overall 30-d mortality |
86% (n = 61) 81% (n = 56) 5.6% (n = 4) |
82% (n = 68) 67% (n = 56) 4.8% (n = 4) |
P = .341 P = .82 |
de Athayde Soares et al, 202077 | Perioperative mortality | 11.1% (n = 2) | 19.3% (n = 6) | P = .03 |
Multivariate Cox regression analysis of factors associated with survival | Rutherford classification, gender, kidney disease, diabetes, segment occluded, fasciotomy | P > .05 | ||
Type of surgery: CDT related to increased mortality; HR 1.330 (95% CI: 0.542-1.543) | P = .26 | |||
Overall survival at 720 d post intervention | 84.7% | 69.2% | Kaplan-Meier curve P = .822 | |
Escobar et al, 201778 | Perioperative mortality | 3.8% (n = 2) Mesenteric ischemia and pulmonary embolus |
0 | NR |
Gandhi et al, 201879 | Perioperative mortality | 1.9% (n = 1) | 0 | P = 1.0 |
Gong et al, 20211 Included large bore catheters, AngioJet, and Rotarex | Mortality | 1.8% (n = 1) | 2.4% (n = 1) | P = 1.0 |
Muli Jogi et al, 201882 Included both AngioJet and Rotarex] | Overall 30-d mortality | 3.6% (n = 1) | 8% (n = 7) | P = .425 |
Vacuum Aspiration (Indigo) | ||||
No studies met our inclusion criteria for this mechanical thrombectomy device | ||||
Rotational (Rotarex) | ||||
Gong et al, 202,11 included large bore catheters, AngioJet, and Rotarex (see findings discussed elsewhere in this assessment)a | ||||
Hundt et al, 201380 | Mortality | 0 | 0 | NS |
Kronlage et al, 201781 | Survival among non-critically ill, at 12 mo | Overall survival across study group: 96.02%b | Kaplan-Meier curve P = .86 | |
Survival among critically ill, at 12 mo | Overall survival across study group: 65%b | Kaplan-Meier curve P = .12 | ||
Muli Jogi et al, 2018,82 included both AngioJet and Rotarex (see findings discussed elsewhere in this assessment)c | ||||
Ultrasound Assisted (EKOS) | ||||
Chait et al, 201974,d | 30-d mortality | 4% (n = 1) | 4% (n = 3) | P = .97 |
Schernthaner et al, 201484 | Perioperative mortality | 0 | 0 | NS |
Event free survival | Median event-free survival: 43 mo (range: 29-64 mo) | Median event-free survival: 21 mo (range: 16-59 mo) | P = .061 |
Abbreviations: CDT, catheter-directed thrombosis; CI, confidence interval; HR, hazard ration; MT, mechanical thrombectomy; NR, not reported; NS, not significant; PMT, pharmacomechanical thrombectomy.
Gong et al1 compared treatment groups of large bore catheters versus AngioJet versus Rotarex.
Data for each study group presented as Kaplan-Meier curves, specific details not provided.
Muli Jogi et al, 201882 compared catheter-directed thrombolysis versus AngioJet and Rotarex.
While all patients in both groups also received AngioJet, the study was designed to isolate the effects of EKOS.